Migraine and sleep disorders. Migraine
Conditions
Interventions
Intervention 1: Intervention group: Consumption of propranolol with dosage 1 mg / kg divided into 2 doses Along One tablet of melatonin 3 mg daily for three months. Intervention 2: Control group: Con
Sponsors
Hamedan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
5 Years to 15 Years
Inclusion criteria
Inclusion criteria: 1- Children aged 5 to 15 years 2. A definitive diagnosis of migraine disease by a neurologist. 3- Rejection of other causes of headache 4. Family consent to attend the project 5. Suitable for the onset of migraine prophylaxis: more than one attack per week, more than a disabling attack (leading to school absenteeism or dysfunction, PEDMIDAS of more than 20 6. Sleep disturbance includes: late sleep, early waking, low sleep, frequent waking up during nighttime sleep.
Exclusion criteria
Exclusion criteria: 1-For any reason, patients tend to continue to study or change the diagnosis. 2- Cases of other underlying illnesses that do not have the ability to use propranolol.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Migraine. Timepoint: Patients are evaluated 1 month after treatment and in those who continue to receive treatment at the end of the first three months the rate of recovery is assessed. Method of measurement: The severity of migraine headaches is assessed using the PEDMIDAS method.;Sleep disorders. Timepoint: Patients are evaluated 1 month after treatment and in those who continue to receive treatment at the end of the first three months the rate of recovery is assessed. Method of measurement: Child Sleep Disorder will be assessed using the CSHQ Child Sleep Habits Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAbbas Ali Abdollahi
Hamedan University of Medical Sciences
Outcome results
None listed